Prediction of recurrence with the Oncotype DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial.

Authors

Frederique Penault-Llorca

Frederique Madeleine Penault-Llorca

Centre Jean Perrin, Clermont-Ferrand, France

Frederique Madeleine Penault-Llorca , Thomas Filleron , Bernard Asselain , Frederick L. Baehner , Pierre Fumoleau , Magali Lacroix-Triki , Steven M. Butler , Farid Jamshidian , Diana B. Cherbavaz , Steven Shak , Lise Roca , Christine Sagan , J Lemonnier , Anne-Laure Martin , Henri Hubert Roche

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Genomic and Epigenomic Biomarkers

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 11052)

DOI

10.1200/jco.2014.32.15_suppl.11052

Abstract #

11052

Poster Bd #

334

Abstract Disclosures